Supernus Pharmaceuticals | SUPN - Market Capitalization


Supernus Pharmaceuticals reported $2.29B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 171.01B 12.96B Sep/2026
ANI Pharmaceuticals USD 1.88B 133M Jun/2026
Aurora Cannabis CAD 318.09M 145.93M Nov/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Canopy Growth CAD 582.57M 25.44M Jun/2026
Cara Therapeutics USD 30M 336M Mar/2026
Corcept Therapeutics USD 9.33B 5.02B Jun/2026
Eisai JPY 1.2T 219.32B Jun/2026
Eli Lilly USD 1.09T 40.33B Sep/2026
Novo Nordisk A/S DKK 1.4T 373.76B Jun/2026
Pacira USD 1.69B 694M Nov/2026
Pfizer USD 138.44B 15.37B Jun/2026
Supernus Pharmaceuticals USD 2.51B 193M Sep/2026
United Therapeutics USD 23B 2.19B Jun/2026
Xeris Pharmaceuticals USD 1.37B 370M Jun/2026